FDA Advisory Committee supports use of tobramycin inhalation powder from Novartis for patients with cystic fibrosis
Source URL: https://qa1.novartis.us/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0
List of links present in page
- https://qa1.novartis.us/us-en/us-en/news/media-releases/fda-advisory-committee-supports-use-tobramycin-inhalation-powder-from-novartis-patients-cystic-fibrosis-0